Is HKEX ready to re­turn to biotech busi­ness? In­no­Care tests wa­ters with hopes to fetch $257M in IPO

The Covid-19 out­break may have forced In­no­Care Phar­ma to post­pone in­vestor meet­ings ahead of its pub­lic de­but on the Hong Kong Stock Ex­change, but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.